Healthcare >> CEO Interviews >> October 17, 2003

Jack Bowman – Neorx Corporation (nerx)

JACK L. BOWMAN, Chairman and Chief Executive Officer of NeoRx Corporation, was appointed Executive Chairman and Chairman of the Board of Directors of NeoRx in March 2003, having served as a Director of NeoRx since 1994. Mr. Bowman was Company Group Chairman of Johnson & Johnson, with global responsibility for most of the company's pharmaceuticals and diagnostics businesses, from 1987 until his retirement in 1993. Prior to joining Johnson & Johnson, he was President of Lederle Laboratories and Corporate Executive Vice President of American Cyanamid. Previously, he held a range of sales, marketing and general management positions with Ciba-Geigy. Mr. Bowman is a Director of Cell Therapeutics, Inc., Celgene Corp., Targeted Genetics Corp., Cellegy Pharmaceuticals, Inc., and Reliant Pharmaceuticals and is an advisor to Bay City Capital LLC. He holds a BEd degree from Western Washington University. Profile
TWST: Give us an overview of NeoRx.

Mr. Bowman: NeoRx is a cancer therapeutics development company. We

recently reached agreement with the FDA, under the Special Protocol

Assessment (or SPA)